ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
28.90
+0.54 (1.90%)
Sep 18, 2026, 4:00 PM EDT - Market closed
ArriVent BioPharma Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Buy Maintains $45 | Buy | Maintains | $45 | +55.71% | Sep 15, 2026 |
| Citi | Citi | Buy Maintains $40 | Buy | Maintains | $40 | +38.41% | Sep 15, 2026 |
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Sep 15, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $43 | Buy | Maintains | $43 | +48.79% | Sep 14, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $47 | Buy | Reiterates | $47 | +62.63% | Aug 17, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $50 | Buy | Maintains | $50 | +73.01% | Aug 13, 2026 |
| BTIG | BTIG | Buy Maintains $42 | Buy | Maintains | $42 | +45.33% | Aug 13, 2026 |
| JonesTrading | JonesTrading | Buy Maintains $45 | Buy | Maintains | $45 | +55.71% | Aug 12, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.